Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)

NCT04360486 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

FED

Sponsor class

Conditions

Severe Acute Respiratory Syndrome Coronavirus 2

Interventions

BIOLOGICAL: Anti-Sars-CoV-2 Convalescent Plasma

Sponsor

U.S. Army Medical Research and Development Command